Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hypoxic-ischemic Encephalopathy
and you are
under 7
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to to evaluate the safety and efficacy of hyperbaric oxygen in term gestation newborn infants with hypoxic-ischemic encephalopathy..

Provided treatments

  • Device: hyperbaric oxygen
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02894866. The sponsor of the trial is Nanfang Hospital of Southern Medical University and it is looking for 250 volunteers for the current phase.
Official trial title:
Effect of Hyperbaric Oxygen Therapy on Neonatal Hypoxic-Ischemic Encephalopathy